ID
36444
Beschreibung
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01326000 Brief Summary: This randomized, multicenter, open label study will evaluate the safety and efficacy of RO5083945 in combination with FOLFIRI as compared to FOLFIRI plus cetuximab or FOLFIRI alone as second line treatment in patients with metastatic colorectal cancer. Patients will be randomized to receive RO5083945 (1400 mg intravenously on Day 1 and Day 8 and every 2 weeks thereafter) plus FOLFIRI standard iv chemotherapy or FOLFIRI plus cetuximab (400 mg/m2 iv on Day 1 followed by 250 mg/m2 iv every week) or FOLFIRI alone. Anticipated time on study treatment is until disease progression or unacceptable toxicity occurs.
Link
https://clinicaltrials.gov/show/NCT01326000
Stichworte
Versionen (2)
- 15.01.19 15.01.19 -
- 14.05.19 14.05.19 -
Rechteinhaber
Hoffmann-La Roche
Hochgeladen am
14. Mai 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
RO5083945, FOLRIFI and Cetuximab in Colorectal Cancer NCT01326000
Eligibility Criteria
- StudyEvent: Eligibility
Beschreibung
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschreibung
Prior anti-EGFR treatment
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1443775
- UMLS CUI [1,2]
- C1514463
- UMLS CUI [1,3]
- C4055105
Beschreibung
Prior irinotecan treatment
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0123931
Beschreibung
The participant should not have had radiotherapy within the last 4 weeks before first dose of study drug (except for limited field palliative radiotherapy for bone pain relief) (if so he is to be excluded)
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0279134
- UMLS CUI [1,2]
- C0332185
Beschreibung
CNS metastasis
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0686377
Beschreibung
Autoimmune disorders
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0262926
- UMLS CUI [1,2]
- C0004364
- UMLS CUI [2,1]
- C0205177
- UMLS CUI [2,2]
- C0004364
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: Eligibility
C0069717 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C1514463 (UMLS CUI [1,2])
C4055105 (UMLS CUI [1,3])
C0123931 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,2])
C0004364 (UMLS CUI [1,2])
C0205177 (UMLS CUI [2,1])
C0004364 (UMLS CUI [2,2])